Don’t miss out - Get your tickets early!

Join this FREE WEBINAR presented by Beth Baughman DuPree (USA).

TOPIC: Existential Crisis - Improving the Odds of Surviving Cancer through the Mental Health ‘Code Cart’: The Promise of tVNS and Psychedelic-Assisted Therapies

Traditionally, cancer treatment has focused on what we do as physicians to eradicate cancer from the physical body utilizing a combination of surgery, radiation and chemotherapy. Although we have made major strides in cancer diagnosis and treatment, we have opportunities to improve the path to survivorship. Patients come into a cancer diagnosis with a lifetime of lived experiences, including those viewed as positive as well as adverse childhood experiences. A cancer diagnosis initiates an existential spiritual crisis that provides a unique opportunity to focus on the psychosocial emotional wellbeing of the individual. Antidepressants fail miserably in oncology patients. Therefore, turning to novel electroceutical interventions, trauma therapy, plant medicines and psychedelic-assisted therapies provide a new path for us to shift gears in cancer care survivorship.

Objectives:

Evaluate and understand the importance of accessing Adverse Childhood Experiences (ACE’s) in cancer patients
Create a strategy to utilize plant medicines and psychedelic-assisted therapies in healing PTSD, depression and alleviating the existential crisis of cancer
Recognize that high Vagal nerve activity is associated with better cancer prognosis, including slower tumor progression and increased survival time
Applying HRV (heart rate variability )measurements to assess the level of CNS Vagus nerve activation
Explore a novel strategy for prevention of post-MDMA comedown/hangover utilizing tVNS

EVENT DETAILS

DATE: 25th March 2026
TIME: 11:55am (AEDT) for 12:00pm start, finishing at 1:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online - a link will be emailed to you with the viewing details

ABOUT THE PRESENTER

Beth Baughman DuPree (USA) MD, FACS, ABOIM
Medical Doctor

Dr. Beth Baughman DuPree, M.D. is board-certified in surgery and integrative/holistic medicine with thirty-eight years of experience in the surgical management of breast cancer. She holds a Certificate in Psychedelic-Assisted Therapies and Research from CIIS, MAPS and Synthesis Institute. Dr DuPree is committed to bring transformative technologies to the forefront of western medicine. She believes that cancer survivorship begins with mental wellbeing. Dr. DuPree earned her medical degree from Drexel University and her undergraduate degrees in behavioral neuroscience and the history and philosophy of science at the University of Pittsburgh. She completed her general surgery residency at Albert Einstein Medical Center in Philadelphia and has served as an adjunct assistant professor of surgery at the University of Pennsylvania. Dr DuPree has the natural ability to connect with every audience. She works at Redeemer Health, Huntingdon Valley PA, a Cooper- MD Anderson Cancer Affiliate. She is an author, speaker and educator.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.